NCPA Reacts: Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action
Investigation confirms massive middlemen employ tactics like steering, inflated costs, low reimbursements, & harmful contractual terms, that hurt patients and independent pharmacies.